Appeal No. 2001-1909 Page 3
Application No. 09/016,786
1. Claims 50-52 and 54 stand rejected under 35 U.S.C. § 103(a) as being
unpatentable over Koltringer.
2. Claims 50-61 stand rejected under 35 U.S.C. § 103(a) as being unpatentable
over Koltringer by itself or in combination with Zappia or Serfontein.
3. Claims 56-61 stand rejected under 35 U.S.C. § 103(a) as being unpatentable
over Koltringer by itself or in combination with Zappia or Serfontein, further in
view of Briggs.
4. Claims 56-57 and 59-61 are rejected under 35 U.S.C. § 103(a) as being
unpatentable over 1) Koltringer by itself or in combination with Zappia or
Serfontein, or 2) Koltringer by itself or in combination with Zappia or
Serfontein, further in view of Briggs as set forth above, further in view of
either Edgren or Radebaugh.
BACKGROUND
The specification (p. 1), describes the invention as related to
methods for treating disease states, and particularly to a method for the
prevention and treatment of certain disease states in humans by the
continuous administration of vitamins and minerals.
The invention is based on (specification, p. 3)
[t]he discovery that the efficacy of vitamins and other nutritional agents in
treating and preventing various disease states may be improved by
administering therapeutically effective levels of these agents on a
substantially continuous, i.e., over 24-hour period.
Three aspects to the invention are disclosed (see specification, pp. 3-4):
1. “a method of reducing the concentration of lipid peroxides formed by the
autoxidation of lipids in a human, … on a substantially continuous 24-hour
basis, a therapeutically effective amount of a pharmaceutically-acceptable
antioxidant agent”;
2. “a method of reducing the concentration of oxygen free radicals in a
human, … on a substantially continuous 24-hour basis, a therapeutically
effective amount of a pharmaceutically-acceptable antioxidant agent”;
and,
3. “a method of improving the regeneration of nerve tissue in a human …,
which comprises administering to the human, on a substantially
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007